NYSDOH/AI The Role of Methadone in HIV Prevention And Treatment Sharon Stancliff, MD Medical Consultant AIDS Institute New York State Department of Health.

Slides:



Advertisements
Similar presentations
Perinatal Substance Abuse: Methadone Maintenance Treatment Presented by: Toni Royer, MHS, NCGC, CAC-AD Executive Director, ARS Pantops Clinic.
Advertisements

Mady Chalk, PhD., MSW Treatment Research Institute November, 2013.
13 Principles of Effective Addictions Treatment
Dosing and patient management requirements during induction, stabilization, and detoxification with buprenorphine Matthew A. Torrington MD Clinical Research.
Medication Assisted Treatment: An Introduction Deborah A. Orr, Ph.D., RN Remington College School of Nursing.
Swinomish Wellness Program
University Hospital “Sisters of Charity” Psychiatric Clinic Vinogradska c. 29, 1000 Zagreb, Croatia Davor Moravek Addiction and psychotic.
© 2006 McGraw-Hill Higher Education. All rights reserved. Chapter 18 Treating Substance Abuse and Dependence.
© 2006 McGraw-Hill Higher Education. All rights reserved. Chapter 2 Drug Use As A Social Problem.
Copyright Alcohol Medical Scholars Program 1 Opioid Agonist Treatment: “Trading one substance for another?” Joseph Sakai, M.D.
Methadone in Opioid Addiction David Kan, M.D. University of California San Francisco VA Medical Center San Francisco.
.  Introduction to Methadone Maintenance Therapy (MMT)  Introduction to Harm Reduction  Benefits of MMT  One Patient’s Perspective  Misconceptions.
Diagnosis And Treatment Of Prescription Opioid Dependence Steven W. Clay, D.O. Associate Professor, Department of Family Medicine Ohio University College.
Implementation in Ohio’s Regional Psychiatric Hospitals.
Suboxone as an Adjunctive Medication, Not Maintenance Dennis M. Donovan, Ph.D. UW Alcohol & Drug Abuse Institute Patricia C. Knox, Ph.D. Recovery Centers.
Continued Use of Illicit Substances: A Retention Based Approach Joanne King, MS Sharon Stancliff, MD Stuart Steiner, MBA Harlem East Life Plan New York,
BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS Module III – Buprenorphine 101.
Medication Assisted Therapy for Opioid Addiction: Methadone and Buprenorphine Andrew J. Saxon, M.D. Veterans Affairs Puget Sound Health Care System and.
Responding to Drug Abuse and Addiction: What Science Says Developed by the National Institute on Drug Abuse (NIDA) National Institutes of Health Bethesda,
C:\laam\lamAPA.ppt 8/04/98 Heroin Addiction Treatment: A Comparison of Methadone and LAAM M. Douglas Anglin, Ph.D. Douglas Longshore, Ph.D. Jeffrey J.
Scientific Evidence Module 2. The evidence of effectiveness Most research is on methadone, much less on other medications Has proven effective for the.
OPIOID SUBSTITUTION THERAPY
For Pain or Not for Pain: Methadone Madness
Methadone ? Methadone and Treatment By: Eleu Pontes CSW.
1 Care for Injection Drug Users (IDUs) with HIV HAIVN Havard Medical School AIDS Initiative in Vietnam.
Managing Hard-to-Manage Patients Sharon Stancliff, MD Medical Consultant New York State Department of Health AIDS Institute New York, NY.
Drug and Alcohol Misuse Dr Mick McKernan. Harm Reduction Philosophy to lessen the dangers drug abuse cause to Individual/society We will never stop drug.
Understanding Drug Abuse and Addiction: What Science Says Developed by the National Institute on Drug Abuse (NIDA) National Institutes of Health Bethesda,
 Methadone is prescribed to relieve moderate to severe pain that has not been relieved by non-narcotic pain relievers.
Ph: Disclaimer: Information on this page is not a substitute for medical consultation.
Special patient groups Module 5. Introduction Worldwide, the majority of people in substitute treatment are men between Even they do not form a.
Module IV - Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS.
Brain Research Institute, UCLA Alison Taylor
Understanding Drug Abuse and Addiction: What Science Says Developed by the National Institute on Drug Abuse (NIDA) National Institutes of Health Bethesda,
Buprenorphine {Suboxone®, Subutex®}
Challenges and Opportunities for the Use of Medications to Treat Chronic Opioid Addiction in the United States Mark W. Parrino, M.P.A. Thursday, April.
Safe Prescribing of Opioids for the Management of Chronic Nonterminal Pain La Tanya Austin, PGY3.
Suboxone and Opioid Trends Joseph Merrill M.D., M.P.H. University of Washington June 16, 2009.
A System to Manage Long Term Opioid Prescribing in the Primary Care Setting Joy Nassar, MD University Medicine Foundation November 16, 2015.
PRESCRITION DRUG ABUSE and the ELDERLY GREGORY BUNT, M.D. Clinical Assistant Professor of Psychiatry NYU School of Medicine Interim Medical Director Samaritan.
Medication Assisted Treatment Daniel T. Brown, D.O. Medical Director, Meridian HealthCare.
Responding to the Opioid Addiction Epidemic Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation Inc. Executive Director, Physicians for.
1 Case Study Claire Biever, RN Morton Home Care Taunton, MA Linda Lebreux, RN, ACRN Medical Manager Infectious Disease Associates Taunton, MA Programs.
Substance Exposed Newborns: Addressing Substance Use Disorder
Medication Assisted Treatment
Gaston County Opioid Data
Drugs and Neuron Communication
10th Annual Susan Li Conference
Medication-Assisted Therapy at Coleman Profession Services
Caldwell County Narcotic Initiative
Price of Drug Addiction
McLean Hospital Division of Alcohol and Drug Abuse
The Burden of Tobacco Use
How Sober Living Homes Can Help You
Medication Assisted Treatment
Substance abuse reveiw
Medication-Assisted Treatment 101: Breaking the Stigma
Information for Network Providers
Opioids in Butte County
Drugs Jan 2018.
Medication Assisted Treatment: Changing the Trajectory of the Opioid Epidemic
The relationship between incarceration and opioid addiction treatment
Are you sick and tired of being sick and tired?
Medically assisted treatment
Medication Assisted Treatment of Opioid Use Disorder
Many post-MI patients are not receiving optimal therapy
Presentation transcript:

NYSDOH/AI The Role of Methadone in HIV Prevention And Treatment Sharon Stancliff, MD Medical Consultant AIDS Institute New York State Department of Health

NYSDOH/AI Drug Use and HIV Injection of heroin and cocaine is the driving force behind HIV in New York State

NYSDOH/AI Addiction Opiates interact with receptors for endogenous peptides. Short term changes in the dopamine secreting neurons, such as atrophy are documented Long term changes are suspected.

NYSDOH/AI Genetics Twin and adoption studies show a strong familial trend in alcoholism Addictive disorders are common among the families of heroin addicts Anthenelli

NYSDOH/AI “Drug Addiction is a Brain Disease” Alan Leshner, PhD National Institute of Drug Abuse Director

NYSDOH/AI National Institute of Health “Methadone is the most effective treatment for heroin addiction.” National Institute of Health Consensus Development Conference on the Medical Treatment of Heroin Addiction

NYSDOH/AI Methadone A synthetic opiate with a hour half- life Methadone Maintenance Treatment (MMT) was first implemented by Dole and Nyswander in the 1960s as most “detoxed” addicts relapsed to heroin use

NYSDOH/AI Methadone Usual effective dose: mg range:5mg- >500 Clinical response guide dose Rettig, Leavitt 80-90% of those stopping MMT will return to heroin use so treatment is long term Ball, Magura

NYSDOH/AI Methadone Safe during pregnancy Kandall No known long term detrimental effects Novick MMT is usually accompanied by counseling and sometimes other requirements

NYSDOH/AI Benefits of Methadone Maintenance

NYSDOH/AI Reduction in Heroin Use Given a sufficient dose virtually all heroin users will stop using heroin At lesser doses heroin use is decreased. Ball 1991

NYSDOH/AI MMT patients are 3-6 times less likely to become HIV positive when compared to out- of-treatment heroin users. Metzger, Drucker, Gibson, Hartel HIV Prevention

NYSDOH/AI Reduction in HIV seroconversion: a prospective study Comparison of opiate users in and out of methadone treatment Those out of treatment reported more risk behavior for HIV In treatment: 3.5% seroconverted, Out- of-treatment 22% seroconverted Metzger

NYSDOH/AI HIV positive heroin users on methadone are hospitalized less often and live longer than their counterparts who are not on methadone Weber, Newschaffer, Laine Improved outcome in HIV

NYSDOH/AI Other Benefits A fourfold reduction in suicide A fourfold reduction in lethal overdose Capelhorn Reductions in sex work Bellis Reduction in crime Hubbard, Appel

NYSDOH/AI Issues in Methadone Prescribing

NYSDOH/AI Over regulation Available only in methadone clinics Frequent attendance required Limited number of slots Medical maintenance has been shown to be successful outside of these constraints

NYSDOH/AI Under Dosing A 1995 study of selected MMTPs found an average dose of less than 59mg 2/3s of the clinics set a dose ceiling of mgs D”Aunno

NYSDOH/AI Premature discharge A 1995 study found that the majority of clinics encourage detox after only 1 year of treatment Relapse can be deadly- Zanis found 8.2% mortality among 110 pts. leaving MMTP but only 1.2% among 397 remaining in treatment

NYSDOH/AI Misunderstandings about methadone Patients often believe that methadone causes bone or liver damage. Physicians may have misconceptions about pain management in methadone patients. It is also erroneously believed that MMT leads to cocaine use.

NYSDOH/AI MMT patients are judged by: Family Friends Physicians Social service providers Employers Politicians Drug users

NYSDOH/AI Stigmatization by drug Treatment Providers MMT patients are discouraged from speaking at Narcotics Anonymous meetings Narcotics Anonymous Bulletin Many facilities treating cocaine and alcohol abuse bar methadone

NYSDOH/AI Role of the Primary Care Provider Education of current and potential MMT patients and their families Understanding medical issues such as drug interactions Working with clinics to ensure the best possible care for patients

NYSDOH/AI Drug Interactions DRUGS WHICH MAY LOWER PLASMA LEVELS OF METHADONE Phenobarbital Carbamazepin (Tegretol) Phenytoin (Dilantin )** Ritonavir (Norvir) ** Major effect, may require large methadone dose increases Nevirapine (Viraimmune)** Rifampin** Efavirenz (Sustiva)** Abacavir ( Ziagen) ethanol (chronic use)

NYSDOH/AI Drug Interactions II DRUGS WHICH MAY INCREASE PLASMA LEVELS OF METHADONE (none are major problems) Amitriptyline (Elavil) Cimetidine (Tagamet) Diazepam (Valium) Ethanol ( acute use) Ketoconazole (Nizoral) Zidovudine (AZT) levels may be increased by methadone. DRUGS WHICH ARE CONTRAINDICATED Pentazocine (Talwin), Tramadol (Ultram)

NYSDOH/AI For more HIV-related resources, please visit